Eight Roads-backed PlasmaGen Biosciences raises Rs 150 crore at Rs 1,500 crore valuation

PlasmaGen Biosciences has raised Rs 150 crore led by ViNS Bioproducts, with participation from high-net-worth individuals (HNIs), family offices, pharma entrepreneurs, and existing investors. The Bengaluru-based startup that’s backed by Eight Road Ventures secured the funding at a valuation of over Rs 1,500 crore.

The lead investor, ViNS, a 28-year old pharma company, develops and manufactures antivenom for snake and scorpion bites, antitoxins for tetanus, diphtheria, gangrene, and anti-rabies serums.

Founded in 2010, PlasmaGen develops and…